R&D Tax Incentives

R&D Tax Incentives Hong Kong — Section 16B

Hong Kong's enhanced R&D deduction allows up to 300% deduction on qualifying R&D expenditure. Most companies significantly underutilise this — leaving hundreds of thousands on the table every year.

香港会计师公会注册 24小时回复 固定收费 100% 保密
免费咨询
300% Enhanced deduction rate (first HKD 2M)
200% Rate on expenditure above HKD 2M
100% Basic deduction (all qualifying R&D)

R&D Tax Incentives

Hong Kong's enhanced R&D deduction allows up to 300% deduction on qualifying R&D expenditure. Most companies significantly underutilise this — leaving hundreds of thousands on the table every year.

⚠️

⚠ Most HK Companies Underclaim R&D Deductions

IRD's DIPN 49 defines qualifying R&D broadly — including software development, product improvement, and process R&D. Many companies expense R&D without claiming the enhanced deduction, missing the uplift that turns a 16.5% deduction into a 300% deduction on the first HKD 2 million.

常见困扰

您是否正面临以下税务问题?

Identifying Qualifying Expenditure

Not all R&D spending qualifies for the enhanced rate. Wages, equipment, and contracted research at prescribed institutions qualify; market research and routine testing do not.

⚠ Risk: Overclaiming non-qualifying spend → IRD disallowance + penalties

Prescribed Research Institutions

The 300%/200% enhanced rate applies only to R&D outsourced to prescribed research institutions (universities, innovation centres). Internal R&D gets 100% only unless the enhanced conditions are met.

⚠ Risk: Missing prescribed institution qualification → claiming 100% instead of 300%

Documentation Requirements

IRD requires detailed records of R&D activities, project purpose, qualifying expenditure categorisation, and staff time allocation to support enhanced deduction claims.

⚠ Risk: Poor documentation → IRD rejects enhanced claim on audit

IP Ownership Requirement

For the enhanced rate, the R&D must be related to a trade or business carried on in HK, and any resulting IP should be owned or co-owned by the HK entity.

⚠ Risk: IP owned offshore → HK entity loses enhanced deduction entitlement
适合对象

适合对象

Technology and software companies

Companies developing proprietary software, apps, or platforms in HK.

Pharmaceutical and biotech firms

Life sciences companies conducting drug research, clinical trials, or formulation development.

Manufacturing companies with product R&D

Manufacturers improving products or production processes through systematic R&D.

Companies partnering with HK universities

Businesses with research collaborations with HKUST, HKU, CUHK, or PolyU.

服务范畴

服务范畴

R&D Expenditure Review

Analyse all R&D expenditure to identify qualifying amounts for the basic and enhanced deductions under s.16B IRO.

Per DIPN 49 guidance

Enhanced Deduction Claim

Prepare the R&D enhanced deduction claim for inclusion in the profits tax return, with full documentation package.

Project summaries + expenditure schedules

Prescribed Institution Structuring

Advise on how to structure R&D partnerships with HK prescribed research institutions to maximise the 300% rate.

University collaboration agreement review

R&D Tax Planning Strategy

Develop a multi-year R&D tax strategy — identifying optimal project structures, expenditure timing, and IP ownership arrangements.

Linked to patent box planning
服务流程

简单、高效、专业

1

R&D Activity Mapping

Interview technical and finance teams to map all qualifying R&D activities and expenditure.

1-2 weeks
2

Qualifying Expenditure Analysis

Categorise expenditure by qualifying type and calculate basic vs enhanced claim.

1 week
3

Documentation Preparation

Prepare R&D project summaries and supporting documentation for IRD.

1-2 weeks
4

Annual Review

Annual review to capture new R&D activity and update the deduction claim.

Annual
准备好开始了吗? 无需承诺,随时取消
预约免费咨询
客户成功案例

为真实客户带来真实成果

Case Study

Fintech company — software R&D enhanced claim

HKD 660,000 节省
  • HKD 3.8M annual R&D expenditure identified
  • HKD 2M restructured to HKUST collaboration (300% rate)
  • Additional HKD 1.8M claimed at 200% rate
  • Total deduction: HKD 9.6M vs HKD 3.8M expensed
"We were expensing R&D but never claiming the enhanced deduction. That changes everything."
C
已验证客户 Case Study
Case Study

Medical device manufacturer — R&D + patent box combo

HKD 1,100,000 节省
  • R&D enhanced deduction HKD 580K annual saving
  • Patent box 5% rate on resulting royalty income
  • IP ownership confirmed in HK entity
  • DEMPE substance documented for BEPS compliance
"The combined R&D deduction and patent box saved us seven figures annually."
C
已验证客户 Case Study
★★★★★ 2,400+ 位客户信赖我们的团队
免费咨询

免费专家咨询

立即与资深税务专家联系

  • 免费30分钟初步咨询
  • 资深注册会计师为您服务
  • 无需承诺,随时取消
HKICPA 注册 24小时回复 无需承诺
选择我们的理由

为何选择 TAX.hk

深厚的香港税务专业知识

我们的注册会计师拥有15年以上香港税务经验,时刻掌握税务局的最新动态。

透明固定收费

无按小时计费的意外开支。开始前清楚了解费用。

24小时回复

我们于一个工作日内回复所有咨询,紧急情况4小时内处理。

严格保密

所有客户信息均依据严格的专业保密义务妥善保管。

常见问题

常见问题

快速解答您的疑问

Qualifying R&D under s.16B(1) includes activities that are innovative, involve technical uncertainty, are systematic or investigative in nature, and aim to advance knowledge or create new/improved products, processes, or services. Routine product testing, market research, and quality control do NOT qualify.
The first HKD 2 million of qualifying R&D expenditure paid to a prescribed research institution attracts a 300% deduction — meaning a HKD 2M payment reduces assessable profits by HKD 6M. Expenditure above HKD 2M at a prescribed institution attracts 200%. In-house R&D qualifies for 100% (basic deduction only), plus potentially 200% if conditions met.
The list of prescribed research institutions includes the eight HK universities (HKU, CUHK, HKUST, PolyU, CityU, HKBU, HSUHK, EdUHK), various government-funded R&D centres, and other approved institutions listed in Schedule 45 of IRO. The list is updated periodically.
Only if the Mainland lab is a prescribed research institution under HK law — which most are not. For non-prescribed institution outsourcing, only the basic 100% deduction applies (if the expenditure otherwise qualifies). Subcontracting R&D to overseas non-prescribed labs does not attract enhanced rates.
Yes. Capital expenditure on R&D assets (equipment, machinery used for R&D) qualifies for capital allowances under s.16B(3), not the enhanced revenue deduction. Revenue expenditure (staff costs, consumables, payments to research institutions) qualifies for the enhanced deduction. The distinction requires careful analysis.
R&D deductions that cannot be utilised in the year because the company has insufficient profits can be carried forward indefinitely under s.19C IRO and offset against future profits. This makes early-stage R&D expenditure valuable even when the company is loss-making.

准备好开始了吗?

立即预约资深香港税务专家的免费咨询。

本页面仅提供一般信息。如需针对您个人情况的建议,请咨询合资格的香港税务专业人士。